Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lück

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Zeitschrift Fur Kardiologie|May 1, 1977
[Hemodynamics after mitral valve replacement with Starr-Edwards, Björk-Shiley and Lillehei-Kaster protheses (author's transl)]K Haerten, A Both, J Lück, et al.
Zentralblatt Fur Gynakologie|September 25, 2004
[Epigenetic changes in breast cancer shown by aberrant promoter methylation]U Lehmann, F Länger, G Celikkaya, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
A phase I study. UFT/leucovorin combined with paclitaxel for anthracycline-pretreated advanced breast cancerU Scholz, H J Lück, U Canzler, et al.
Breast Cancer Research and Treatment|October 10, 2006
Legumain expression as a prognostic factor in breast cancer patientsJessica Gawenda, Frank Traub, Hans J Lück, et al.
Oncology Letters|April 30, 2017
Anti-apoptotic protein Lifeguard does not act as a tumor marker in breast cancerViktor Maurer, Kerstin Reimers, Hans J Lück, et al.
Zentralblatt Fur Gynakologie|June 17, 2000
[Anthracyclines in therapy of ovarian carcinoma: a systematic review of primary and 2nd-line therapy after platinum]A du Bois, H J Lück, J Pfisterer, et al.
Breast Cancer Research and Treatment|April 26, 2006
Prognostic impact of Skp2 and p27 in human breast cancerFrank Traub, Michael Mengel, Hans J Lück, et al.
European Journal of Gynaecological Oncology|January 1, 1995
Cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid (CMFF) as first line chemotherapy for treatment of advanced breast cancer. A pilot studyM Glaubitz, H H Günter, R J Lellé, et al.
Zeitschrift Fur Kardiologie|May 1, 1977
[Evaluation of social status and hemodynamic results four to six years after prosthetic valve replacement (author's transl)]U Führer, A Both, G Fischer, et al.
Gynecologic Oncology|January 1, 1996
Paclitaxel-induced "recall" soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low dosesA du Bois, F G Kommoss, J Pfisterer, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Zeitschrift Fur Kardiologie|May 1, 1977
[Hemodynamics after mitral valve replacement with Starr-Edwards, Björk-Shiley and Lillehei-Kaster protheses (author's transl)]K Haerten, A Both, J Lück, et al.
Zentralblatt Fur Gynakologie|September 25, 2004
[Epigenetic changes in breast cancer shown by aberrant promoter methylation]U Lehmann, F Länger, G Celikkaya, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
A phase I study. UFT/leucovorin combined with paclitaxel for anthracycline-pretreated advanced breast cancerU Scholz, H J Lück, U Canzler, et al.
Breast Cancer Research and Treatment|October 10, 2006
Legumain expression as a prognostic factor in breast cancer patientsJessica Gawenda, Frank Traub, Hans J Lück, et al.
Oncology Letters|April 30, 2017
Anti-apoptotic protein Lifeguard does not act as a tumor marker in breast cancerViktor Maurer, Kerstin Reimers, Hans J Lück, et al.
Zentralblatt Fur Gynakologie|June 17, 2000
[Anthracyclines in therapy of ovarian carcinoma: a systematic review of primary and 2nd-line therapy after platinum]A du Bois, H J Lück, J Pfisterer, et al.
Breast Cancer Research and Treatment|April 26, 2006
Prognostic impact of Skp2 and p27 in human breast cancerFrank Traub, Michael Mengel, Hans J Lück, et al.
European Journal of Gynaecological Oncology|January 1, 1995
Cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid (CMFF) as first line chemotherapy for treatment of advanced breast cancer. A pilot studyM Glaubitz, H H Günter, R J Lellé, et al.
Zeitschrift Fur Kardiologie|May 1, 1977
[Evaluation of social status and hemodynamic results four to six years after prosthetic valve replacement (author's transl)]U Führer, A Both, G Fischer, et al.
Gynecologic Oncology|January 1, 1996
Paclitaxel-induced "recall" soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low dosesA du Bois, F G Kommoss, J Pfisterer, et al.
Pageof 5